Merck acquires Imago BioSciences for $1.35 billion
Merck, a US multinational pharmaceutical company, announced it would acquire Imago BioSciences for $1.35 billion.
Drugs
Pharma
Drugs
Medical
Pharma
Swedish researchers find possible biomarker for Covid-19
Swedish researchers have found a potential biomarker for severe Covid-19 disease that has claimed the lives of more than 6.5 million people globally.
Drugs
Pharma
WHO wants pharma companies to disclose govt deals during world health emergencies
WHO drafts an agreement for pharma companies to disclose contract terms for emergency vaccines
Drugs
Health
Pharma
Drug resistance to malaria on the rise in Africa, WHO says
Antimalarial drug resistance in Africa is a severe cause for concern and parasite resistance to artemisinin medicine has emerged in the Greater Mekong.
Drugs
Health
Pharma
Fentanyl vaccine breakthrough maybe a gamechanger for opioid epidemic
Scientists have developed a vaccine against fentanyl addiction that works in rats and is ready for human trials
Drugs
Health
Pharma
Amazon to start virtual clinics in US
Amazon announced it would set up virtual healthcare facilities in 32 states in the US for more than 20 health conditions and acquire.
Drugs
Pharma
FDA approves Immunogen’s drug for advanced ovarian cancer
The Food and Drug Administration approved a new treatment for patients with advanced ovarian cancer — an antibody that delivers a targeted dose.
Drugs
Pharma
Roche’s Alzheimer’s drug fails to meet primary target
Roche, a Swiss drugmaker, announced its Alzheimer's drug did not meet the primary goal of slowing the disease during two clinical trials
Drugs
Pharma
Medicines to treat drug-resistant TB highly expensive for poor patients
With newer TB drugs to go off patent in 2023, MSF calls on J&J, Otsuka, to lower pricing barriers and allow generic manufacturers.